U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226258) titled 'Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain' on Nov. 06.
Brief Summary: A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Study Start Date: Nov. 07
Study Type: INTERVENTIONAL
Condition:
Osteoarthritis Knee Pain
Intervention:
DRUG: SL1002
SL1002 injectable solution
DRUG: Normal Saline
SL 1002
Recruitment Status: RECRUITING
Sponsor: Saol Therapeutics Inc
Published by HT Digital Content Services with permission from Health Daily Digest....